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Neuropeptides are diverse and evolutionarily ancient regulators of 25 
physiological/behavioural processes in animals. Here we have investigated the evolution 26 
and comparative physiology of luqin-type neuropeptide signalling, which has been 27 
characterised previously in protostomian invertebrates. Phylogenetic analysis indicates 28 
that luqin-type receptors and tachykinin-type receptors are paralogous and probably 29 
originated in a common ancestor of the Bilateria. In the deuterostomian lineage, luqin-30 
type signalling has been lost in chordates but interestingly it has been retained in 31 
ambulacrarians. Therefore, here we characterised luqin-type signalling for the first 32 
time in an ambulacrarian – the starfish Asterias rubens (phylum Echinodermata). A 33 
luqin-like neuropeptide with a C-terminal RWamide motif (ArLQ; 34 
EEKTRFPKFMRW-NH2) was identified as the ligand for two luqin-type receptors in A. 35 
rubens, ArLQR1 and ArLQR2. Furthermore, analysis of the expression of the ArLQ 36 
precursor using mRNA in situ hybridisation revealed expression in the nervous system, 37 
digestive system and locomotory organs (tube feet) and in vitro pharmacology revealed 38 
that ArLQ causes dose-dependent relaxation of tube feet. Accordingly, previous studies 39 
have revealed that luqin-type signalling regulates feeding and locomotor activity in 40 
protostomes. In conclusion, our phylogenetic analysis combined with characterisation of 41 
luqin-type signalling in a deuterostome has provided new insights into neuropeptide 42 
evolution and function in the animal kingdom. 43 
 44 
Neuropeptides play a central role in the control of diverse physiological processes and 45 
behaviours in animals. Furthermore, neuropeptides are evolutionarily ancient mediators of 46 
neuronal signalling and a large number of different neuropeptide signalling pathways were 47 
already present in the common ancestor of protostomes and deuterostomes1–3. The discovery 48 
of neuropeptide signalling systems has been enabled by a variety of experimental strategies4. 49 
The luqin-type neuropeptide system that is the focus of this study was first discovered using a 50 
molecular biological approach where the objective was to identify neuropeptides expressed in 51 
the L5 neuron of the abdominal ganglion in the mollusc Aplysia californica that are 52 
immunoreactive with antibodies to the neuropeptide FMRFamide. A cDNA encoding a novel 53 
precursor protein comprising a peptide with the predicted C-terminal tetrapeptide sequence 54 
QGRFamide was discovered5. Subsequently, the mature peptide derived from this precursor 55 
was identified biochemically as APSWRPQGRFamide and named luqin (LQ) because it is 56 
expressed in the Left Upper Quadrant cells of the abdominal ganglion in A. californica6. 57 
However, prior to this a homolog of luqin (SGQWRPQGRFamide) was discovered in the 58 
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snail Achatina fulica and named Achatina Cardio-Excitatory Peptide (ACEP-1) on account of 59 
its effect in potentiating the beat of the heart ventricle in this species. Furthermore, ACEP-1 60 
was also found to have excitatory effects on neurons and muscles involved in feeding 61 
behaviour in A. fulica7. A third luqin-type peptide (TPHWRPQGRFamide) was discovered in 62 
the pond snail Lymnaea stagnalis and named Lymnaea cardio excitatory-peptide (LyCEP) 63 
because it increases the beating frequency of auricle preparations from this species8. 64 
Concomitant with the discovery of LyCEP, an orphan G-protein coupled receptor (GRL106) 65 
was identified as the receptor for this peptide and thus the first receptor for luqin-type 66 
peptides was discovered8. More recently, analysis of genomic sequence data enabled the 67 
discovery of luqin-type neuropeptides in the annelid Capitella teleta9. Furthermore, the 68 
receptor for the luqin-type peptide WRPGRFamide has been identified in the annelid 69 
Platynereis dumerilii10,11. 70 
Phylogenetic analysis of G-protein coupled neuropeptide receptors has revealed that 71 
molluscan luqin receptors are orthologs of receptors for arthropod neuropeptides that have a 72 
C-terminal RYamide motif – ‘RYamides’3. Additional evidence that lophotrochozoan luqins 73 
and arthropodan RYamides are orthologous was provided by similarity-based clustering 74 
methods 1 and the identification of a conserved motif comprising two cysteine residues in the 75 
C-terminal region of luqin/RYamide-type precursor proteins3. Thus, luqin-type neuropeptides 76 
from lophotrochozoan protostomes (molluscs, annelids) and RYamides from ecdysozoan 77 
protostomes (arthropods, nematodes) were unified as members of a bilaterian family of 78 
luqin/RYamide-type neuropeptides1,3. 79 
RYamides were first identified in crustaceans12–14 and subsequently RYamide 80 
precursor proteins and RYamide receptors were discovered in insects15–17. Analysis of 81 
RYamide expression in Drosophila melanogaster revealed that it is expressed by neurons 82 
that innervate the rectal papillae, organs that mediate water re-absorption in flies. Consistent 83 
with this expression pattern, injection of female mosquitoes with RYamides delays 84 
postprandial diuresis18. RYamides also suppress feeding motivation and sucrose consumption 85 
in the blow fly Phormia regina19 and evidence of role in regulation of feeding has also been 86 
obtained in the crustacean Marsupenaeus japonicus, where expression of the RYamide 87 
precursor gene is downregulated during starvation20. Recently, a detailed molecular and 88 
functional characterisation of luqin/RYamide-type neuropeptide signalling in the nematode 89 
Caenorhabditis elegans has been reported. Consistent with the findings from arthropods, 90 
luqin/RYamide-type signalling suppresses feeding behaviour in C. elegans whilst also 91 
influencing egg-laying, lifespan and locomotor activity21. 92 
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Analysis of the phylogenetic distribution of luqin/RYamide-type receptors has 93 
revealed the presence of orthologs in ambulacrarians (hemichordates and echinoderms) but 94 
not in vertebrates and other chordates (urochordates and cephalochordates)1,3. Thus, the 95 
evolutionary origin of luqin/RYamide-type neuropeptide signalling can be traced to common 96 
ancestor of protostomes and deuterostomes, but with subsequent loss in the chordate lineage. 97 
Furthermore, consistent with this conclusion, precursor proteins comprising candidate ligands 98 
for luqin/RYamide-type receptors have been identified in ambulacrarians but not in 99 
chordates1,22. 100 
Luqin/RYamide-type precursors in ambulacrarians comprise a neuropeptide with a 101 
putative C-terminal RWamide motif, which contrasts with the RFamide/RYamide motif 102 
found in protostomian luqin/RYamide-type neuropeptides. However, there have been no 103 
experimental studies on luqin/RWamide-type neuropeptide signalling in deuterostomes. The 104 
objective of this study was to begin to fill this gap in our knowledge and to accomplish this 105 
we selected the starfish Asterias rubens (Phylum Echinodermata) as an experimental system, 106 
building upon a growing body of data on neuropeptide signalling that have been obtained 107 
from this species22,23. Because of its phylogenetic position as a non-chordate deuterostome, A. 108 
rubens and other echinoderms can provide key insights into the evolution of neuropeptide 109 
signalling systems. This was illustrated recently with deorphanisation of echinoderm 110 
neuropeptide receptors facilitating reconstruction of the evolutionary history of neuropeptide-111 
S/crustacean cardioactive peptide (CCAP)-type signalling24 and gonadotropin-releasing 112 
hormone (GnRH)/corazonin-type signalling25. Furthermore, the pentaradial symmetry of 113 
adult echinoderms provides a unique context for comparative analysis of neuropeptide 114 
function in the animal kingdom26–28. 115 
Here we report the first biochemical, anatomical and pharmacological characterisation 116 
of the luqin/RWamide-type neuropeptide signalling in a deuterostome, the starfish A. rubens, 117 
providing new insights into the evolution and comparative physiology of neuropeptide 118 
signalling systems in the animal kingdom. 119 
   120 
! 5!
Results  121 
Sequencing of a luqin-type precursor and a luqin-type neuropeptide in A. rubens.122 
 Cloning and sequencing of a cDNA encoding a luqin-type precursor protein (ArLQP) 123 
confirmed a previously reported sequence assembled from A. rubens transcriptome data22. 124 
ArLQP is a 106-residue protein, including a predicted 44-residue N-terminal signal peptide 125 
and a predicted luqin-like peptide sequence (EEKTRFPKFMRWG), followed by a dibasic 126 
cleavage site (KR) (Fig. 1A). Analysis of A. rubens radial nerve cord extracts using mass 127 
spectrometry confirmed the presence of the predicted luqin-like peptide, with post-128 
translational conversion of the C-terminal glycine to an amide group (ArLQ; 129 
EEKTRFPKFMRW-NH2; Fig 1B.) Alignment of ArLQP with luqin/RYamide-type 130 
precursors from other species revealed several similarities. ArLQP comprises a single 131 
luqin/RYamide-like neuropeptide, a feature shared with luqin-type precursors in other 132 
echinoderms and in hemichordates and annelids (Fig 1C). This contrasts with precursor 133 
proteins in ecdysozoans (insects, nematodes and the priapulid Priapulus caudatus), which 134 
comprise two luqin-like RYamides (Fig 1C). Interestingly, precursors comprising either one 135 
or two luqin-type peptides are found in molluscs (Fig. 1C). A distinctive feature of 136 
luqin/RYamide-type precursors that has been reported previously1,3 are a pair of cysteine 137 
residues located in the C-terminal region and separated by ten other amino acid residues. As 138 
can be seen in the alignment in Fig. 1C, this feature is conserved in ArLQP and in the 139 
majority of luqin/RYamide precursors from other species, with the exception of D. 140 
melanogaster where one of the cysteines is replaced with an arginine residue and C. elegans 141 
where the two cysteines are separated by eight amino acid residues. Phylogenetic analysis of 142 
luqin/RYamide-type precursors revealed that they cluster in three distinct clades: 143 
deuterostomian precursors comprising a neuropeptide with a C-terminal RWamide motif, 144 
lophotrochozoan precursors comprising one or two neuropeptides with a C-terminal RFamide 145 
motif and ecdysozoan precursors comprising two neuropeptides with a C-terminal RYamide 146 
motif (Fig. 1C; Supplementary Fig. 1). 147 
 148 
Identification of two G-protein coupled receptors in A. rubens that are activated by 149 
ArLQ.  To identify candidate receptors for ArLQ, we performed BLAST analysis of 150 
A. rubens neural transcriptome sequence data using the deorphanised P. dumerilii Luqin 151 
receptor as a query10. Two contigs (1121303 and 1122311) encoding receptors comprising 152 
347 and 388 amino acid residues were identified and named ArLQR1 and ArLQR2, 153 
respectively. Analysis of the sequences of ArLQR1 and ArLQR2 using Protter29 revealed the 154 
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presence of seven transmembrane domains, a feature common to G-protein coupled 155 
receptors30 (Supplementary Figs. 2 and 3). Phylogenetic analysis of relationships of ArLQR1 156 
and ArLQR2 with luqin/RYamide-type receptors and with other receptors that are closely 157 
related to luqin/RYamide-type receptors, including tachykinin (TK)-type receptors and 158 
neuropeptide Y/F (NPY/F) receptors, demonstrated that ArLQR1 and ArLQR2 are orthologs 159 
of the luqin/RYamide-type receptors that have been characterised in other phyla. Thus, in a 160 
tree rooted with thyrotropin-releasing hormone (TRH)-type receptors as an outgroup there is 161 
strong bootstrap support for three distinct clades, a luqin/RYamide receptor clade, a TK 162 
receptor clade and a NPY/F receptor clade, and ArLQR1 and ArLQR2 are positioned within 163 
the luqin/RYamide receptor clade. Furthermore, ArLQR1 and ArLQR2 are positioned in a 164 
branch of the luqin/RYamide receptor clade that includes related receptors from other 165 
ambulacrarians – the sea urchin Strongylocentrotus purpuratus (phylum Echinodermata) and 166 
the acorn worm Saccoglossus kowalevskii (phylum Hemichordata) (Fig. 2).  167 
Having identified ArLQR1 and ArLQR2 as candidate receptors for ArLQ based on 168 
phylogenetic analysis, cDNAs encoding these receptors were cloned and then expressed in a 169 
CHO-cell line expressing apoaequorin and Gα16 to produce the cell systems CHO-ArLQR1 170 
and CHO-ArLQR2. Synthetic ArLQ (EEKTRFPKFMRW-NH2) was then tested as a 171 
candidate ligand for these receptors at concentrations ranging from 1x10−4"M to 1x10−14"M. 172 
ArLQ induced a dose-dependent bioluminescence signal in the CHO-ArLQR1 and CHO-173 
ArLQR2 systems with half-maximal response concentrations (EC50) of 2.4 x 10-8 M and 7.8 x 174 
10-10 M, respectively (Fig. 3). Bioluminescence was observed within 5 s of exposure to 175 
ArLQ, after which the signal decreased slowly (Supplementary Fig. 4). Importantly, no 176 
response to ArLQ was observed in CHO-cells transfected with the vector alone, 177 
demonstrating that the signal observed in CHO-ArLQR1 and CHO-ArLQR2 can be attributed 178 
to the transfected receptors (Fig. 3). The specificity of ArLQR1 and ArLQR2 as receptors for 179 
ArLQ was further assessed by testing three other neuropeptides from A. rubens that are 180 
evolutionarily related and/or exhibit some C-terminal structural similarity with ArLQ:  the 181 
Neuropeptide Y-type peptide ArNPY (pQDRSKAMQAERTGQLRRLNPRF-NH2)31, the 182 
tachykinin-like peptide ArTK2 (GGGVPHVFQSGGIF-NH2)22 and SALMFamide-2 183 
(SGPYSFNSGLTF-NH2)32. These peptides were tested at concentrations ranging from 184 
1x10−4"M to 1x10−13"M but none of them caused activation of the receptors, demonstrating the 185 
specificity of ArLQR1 and ArLQR2 as receptors for ArLQ (Supplementary Fig. 5). Thus, we 186 
conclude that ArLQ is the ligand for ArLQ1 and ArLQ2 in A. rubens. 187 
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ArLQP is expressed by cells in the nervous, digestive and locomotor systems in A. 188 
rubens. To gain insights into the physiological roles of ArLQ in A. rubens, the expression 189 
pattern of ArLQP was examined using mRNA in situ hybridisation. No staining was 190 
observed in experiments with sense probes (Fig 4C inset), demonstrating the specificity of 191 
staining observed with antisense probes (Fig. 4, 5). Cells expressing ArLQP were detected in 192 
the nervous system (Fig. 4) and in the digestive system and tube feet (Fig. 5). 193 
 The main components of the nervous system in starfish are the radial nerve cords that 194 
are located on the underside of each arm and that are linked by a circumoral nerve ring in the 195 
central disk region (Fig. 4A, B; Fig. 5A). Transverse sections of arms revealed stained cells 196 
in radial nerve cords, concentrated laterally in the subcuticular epithelium of the ectoneural 197 
region (Fig. 4C-E). In longitudinal sections of arms stained cells can be seen along the length 198 
of the ectoneural region of the radial nerve cords (Figure 4F, G). The pattern of expression 199 
observed in the circumoral nerve ring was consistent with that observed in the radial nerve 200 
cords (Fig. 4H, I). No cells expressing ArLQP were detected in the hyponeural region of the 201 
radial nerve cords and circumoral nerve ring (Fig. 4C-I).  202 
 Locomotion in A. rubens is mediated by tube feet that are located on the underside of 203 
each arm, with two rows of tube feet on either side of the radial nerve cord (Fig. 4A, 5A). 204 
Cells expressing ArLQP were detected in the basal nerve ring in the disk region of tube feet 205 
(Fig. 5B, C). The digestive system of A. rubens comprises a mouth located on the underside 206 
of the central disk region, which is linked by a short oesophagus to the highly folded cardiac 207 
stomach, which is everted through the mouth during feeding. Aboral to the cardiac stomach is 208 
the pyloric stomach, which is linked to paired digestive organs (pyloric caeca) in each arm by 209 
pyloric ducts (Fig. 4A, 5A). Cells expressing ArLQP were detected in the cardiac stomach 210 
and pyloric stomach, but the density of stained cells was much higher in the cardiac stomach 211 
than in the pyloric stomach (Fig. 5D, E, F). High magnification images of the cardiac 212 
stomach reveal that the stained cells are located close to the basi-epithelial plexus layer and 213 
within the mucosal layer (Fig. 5 E). 214 
 215 
ArLQ causes dose-dependent relaxation of in vitro preparations of tube feet from A. 216 
rubens. Informed by the pattern of expression of ArLQP in A. rubens (see above), we 217 
tested the effects of synthetic ArLQ on the contractile state of in vitro preparations of tube 218 
foot and cardiac stomach preparations. The rationale for this approach was that other 219 
neuropeptides that are expressed in these organs have been found to cause contraction33 or 220 
relaxation27,28 of in vitro preparations. Here we found that ArLQ caused relaxation of tube 221 
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foot preparations that had been pre-contracted with 10 µM acetylcholine (ACh) (Fig. 6A) and 222 
the relaxing effect of ArLQ was dose-dependent when tested at concentrations ranging from 223 
1 x 10-9 M to 1x10-5 M (Fig. 6B). Control tests in which 20 µl of the vehicle (water) was 224 
added to the organ bath had no effect on tube foot contractility. 225 
Previous studies have revealed that the SALMFamide neuropeptide S2 causes 226 
relaxation of tube foot preparations from A. rubens34 and therefore here we compared the 227 
effects of ArLQ and S2 and found that the dose-dependence and magnitude of the effects of 228 
ArLQ were very similar to S2 (Fig. 6B). Interestingly, although expression of ArLQP was 229 
detected in the cardiac stomach of A. rubens (Fig. 5D, E), we found that when tested at 230 
concentrations ranging from 1 x 10-9 M to 1x10-5 ArLQ did not cause relaxation of cardiac 231 
stomach preparations, which had been pre-contracted with artificial seawater supplemented 232 
with 30 mM KCl (Supplementary Fig. 6). 233 
 234 
 235 
  236 
! 9!
Discussion  237 
Previous studies have reported the presence of genes encoding luqin/RYamide-type 238 
precursors and receptors in deuterostomian invertebrates3,22,31. Here we report the first 239 
experimental characterisation of luqin/RYamide-type neuropeptide signalling in a 240 
deuterostome – the starfish Asterias rubens (Phylum Echinodermata).  241 
To investigate the occurrence of luqin/RYamide-type receptors in A. rubens, we 242 
performed a comprehensive analysis of the phylogenetic distribution of luqin/RYamide-type 243 
receptors and their relationships with closely related G-protein coupled neuropeptide 244 
receptors. This was important and necessary because historically some luqin/RYamide-type 245 
neuropeptide receptors have been misnamed. For example, the first receptor for a luqin-type 246 
neuropeptide discovered in the mollusc Lymnaea stagnalis (GRL106) was annotated and 247 
described as a possible ortholog of vertebrate neuropeptide-Y (NPY) receptors8. 248 
Subsequently, the Caenorhabditis elegans receptor Y59H11AL.1 was annotated as a 249 
tachykinin-like receptor35, but a recent experimental study has demonstrated that a 250 
luqin/RYamide-type neuropeptide is the ligand for this receptor21. Incorporating receptor 251 
sequences from a variety of phyla, our phylogenetic analysis revealed that luqin/RYamide-252 
type receptors form a distinct monophyletic group of receptors that is distinct from 253 
tachykinin-type receptors and NPY-type receptors, consistent with findings from a previously 254 
reported analysis of neuropeptide receptor relationships3. Furthermore, we conclude that 255 
luqin/RYamide-type receptors and tachykinin-type receptors are paralogous and probably 256 
arose by gene duplication in a common ancestor of the Bilateria, with NPY-type receptors 257 
being more distantly related and occupying an outgroup position with respect to 258 
luqin/RYamide-type receptors and tachykinin-type receptors. It is noteworthy that positioned 259 
within the clade comprising luqin/RYamide-type receptors are proteins that have been 260 
annotated as NPY-type receptors, including receptors in the priapulid Priapulus caudatus 261 
(XP_014666446.1, XP_014678140.1) and receptors in the gastropod mollusc in which luqin 262 
was originally discovered, Aplysia californica (XP_012937781.1), and in the cephalopod 263 
mollusc Octopus bimaculoides (XP_014786450.1). Therefore, the findings of this paper 264 
provide a basis for re-annotation of these receptors as luqin/RYamide-type receptors.  265 
Inclusion of receptor sequences from echinoderms in our phylogenetic analysis 266 
enabled identification of both luqin/RYamide-type receptors and tachykinin-type receptors in 267 
the starfish A. rubens and the sea urchin S. purpuratus. Thus, two luqin/RYamide-type 268 
receptors were identified in both A. rubens (ArLQR1 and ArLQR2) and S. purpuratus, two 269 
tachykinin-type receptors were identified in A. rubens and one tachykinin-type receptor was 270 
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identified in S. purpuratus. The peptides that act as ligands for echinoderm tachykinin 271 
receptors remain to be determined, although candidate ligands have been proposed22. 272 
Candidate ligands for echinoderm luqin/RYamide-type receptors have also been reported, 273 
including the peptide EEKTRFPKFMRW-NH2 (ArLQ) in the starfish A. rubens3,22. Here we 274 
confirmed the structure of ArLQ by mass spectrometric analysis of an extract of radial nerve 275 
cords from A. rubens. Furthermore, we demonstrated that ArLQ acts as a ligand for both 276 
ArLQR1 and ArLQR2 when these receptors are expressed heterologously in CHO cells. 277 
Thus, the existence of a luqin/RYamide-type signalling system in a deuterostomian 278 
invertebrate has been demonstrated experimentally for the first time.  279 
Characterisation of luqin/RYamide-type signalling in a deuterostome provides a basis 280 
for surveying the phylogenetic distribution and evolution of luqin/RYamide-type 281 
neuropeptide signalling, as illustrated in Fig. 7. The evolutionary origin of luqin/RYamide-282 
type neuropeptide signalling can be traced to the common ancestor of the Bilateria, with 283 
retention in both the protostomian and deuterostomian branches of the animal kingdom. In 284 
lophotrochozoan protostomes, luqin-type neuropeptides have a C-terminal RFamide motif 285 
and cognate receptors have been characterised in molluscs and annelids8–11,36. In ecdysozoan 286 
protostomes, neuropeptides with a C-terminal RYamide motif have been identified as ligands 287 
for luqin/RYamide-type receptors in arthropods and nematodes15,16,21. Thus, we can infer that 288 
a luqin/RYamide-type neuropeptide(s) in the common ancestor of the protostomes would 289 
have had a C-terminal RFamide or RYamide motif. In the deuterostomian branch of the 290 
animal kingdom, we have identified a luqin/RYamide-type neuropeptide with a C-terminal 291 
RWamide motif as the ligand for two luqin/RYamide-type receptors in the starfish A. rubens. 292 
Closely related peptides that also have a C-terminal RWamide motif have been identified in 293 
other echinoderms, including brittle stars31, sea urchins3 and sea cucumbers37. Furthermore, a 294 
gene encoding a precursor protein containing a luqin/RYamide-type neuropeptide with a 295 
RWamide motif has been identified in the hemichordate Saccoglossus kowalevskii3. Thus, we 296 
can infer that a luqin/RYamide-type neuropeptide(s) in the common ancestor of the 297 
ambulacraria would have had a C-terminal RWamide motif. Interestingly, genes encoding 298 
luqin/RYamide-type receptors and precursors have not been identified in chordates 299 
(vertebrates, urochordates, cephalochordates) and therefore it can be concluded that this 300 
signalling system was lost in a common ancestor of the chordates1,3. In the absence of 301 
luqin/RYamide-type signalling system in chordates, we are unable to infer whether or not the 302 
RWamide motif found in ambulacrarian luqin/RYamide-type neuropeptides can be traced to 303 
the common ancestor of deuterostomes. Nor do we have sufficient information to infer the 304 
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characteristics of luqin/RYamide-type neuropeptide(s) in the common ancestor of the 305 
Bilateria, with a C-terminal RWamide, RFamide or RYamide motifs all being possible. 306 
 Comparison of the structures of luqin/RYamide-type precursors in the Bilateria 307 
reveals that in some taxa the precursor contains a single luqin/RYamide-type neuropeptide, 308 
whereas in other taxa the precursor contains two or more luqin/RYamide-type neuropeptides. 309 
However, it is not possible to deduce which is the ancestral condition because in protostomes 310 
both types of precursor are found, in some cases in species belonging to the same phylum 311 
(molluscs). A highly conserved feature of luqin/RYamide-type precursors that can be traced 312 
back to the common ancestor of the Bilateria is the presence of two cysteine residues, 313 
typically separated by ten residues, located in the C-terminal region. Together with the 314 
mature luqin neuropeptide, a peptide comprising this region of the luqin precursor has been 315 
detected in extracts of neural tissue from the mollusc A. californica and named proline-rich 316 
mature peptide38, but its functional significance is unknown. One possibility is that this 317 
region of luqin/RYamide-type precursors is necessary for neuropeptide precursor processing 318 
during its passage through the regulated secretory pathway of neurons. Such a role has been 319 
demonstrated for cysteine-rich neurophysins, which are derived from vasopressin/oxytocin-320 
type neuropeptide precursors and which are required for targeting of vasopressin/oxytocin-321 
type neuropeptides to the regulated secretory pathway39. It is noteworthy that the two 322 
cysteine residues are highly conserved, with the exception of Drosophila melanogaster where 323 
the second cysteine is replaced by an arginine, which may be reflective of a functional 324 
decline of the RYamide gene in this species 18.  325 
Our discovery of luqin/RYamide-type signalling in A. rubens has provided a basis for 326 
the first investigation of the physiological roles of this neuropeptide system in a 327 
deuterostome. Using mRNA in situ hybridisation, the expression pattern of the A. rubens 328 
luqin/RYamide-type precursor (ArLQP) was examined, revealing cells in the ectoneural 329 
region of the radial nerve cords and circumoral nerve ring, in the basal nerve ring of the 330 
locomotory organs (tube foot) and in the cardiac stomach. To put this into context, this 331 
represents a relatively restricted pattern of expression by comparison with the expression 332 
patterns in A. rubens of several other neuropeptide precursors that have been analysed 333 
recently. For example, expression of gonadotropin-releasing hormone (GnRH)-type and 334 
pedal peptide/orcokinin (PP/OK)-type precursors extends to the hyponeural region of the 335 
radial nerve cords and circumoral nerve ring, the body wall and other regions of the digestive 336 
system33,27,28. Furthermore, it has been found that GnRH-type and PP/OK-type neuropeptides 337 
act as muscle contractants or relaxants, respectively, in A. rubens33,27,28. Accordingly, here we 338 
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examined the effects of synthetic ArLQ on the contractility of in vitro preparations of organs 339 
in which ArLQP expression was detected – the tube feet and cardiac stomach. ArLQ caused 340 
dose-dependent relaxation of tube foot preparations but had no observable effect on cardiac 341 
stomach preparations. We conclude, therefore, that ArLQ may act as an inhibitory regulator 342 
of locomotory organ activity in starfish, whilst the absence of an effect of ArLQ on cardiac 343 
stomach contractility suggests that this signalling system is involved in the regulation of other 344 
aspects of stomach function in starfish. 345 
 With the first functional characterisation of luqin/RYamide-type signalling in a 346 
deuterostome, it is of interest to compare with what is known about luqin/RYamide-type 347 
neuropeptide function in protostomes. It is noteworthy that a recently reported functional 348 
analysis of luqin/RYamide-type signalling in the nematode C. elegans revealed a role in 349 
causing a reduction in locomotor activity21. This effect parallels our finding that ArLQ has an 350 
inhibitory effect on the contractility of locomotory organs (tube feet) in starfish. Thus, 351 
collectively these findings from a protostome (C. elegans) and a deuterostome (A. rubens) 352 
may be evidence of an evolutionary ancient role of luqin/RYamide-type signalling in 353 
regulation of locomotor activity in bilaterians. Further studies on a wider range of taxa will 354 
be required to investigate this role of luqin/RYamide-type signalling more extensively. 355 
Like many neuropeptides, luqin/RYamide-type neuropeptides are pleiotropic, with 356 
effects on a variety of physiological processes and behaviours reported. In C. elegans 357 
luqin/RYamide-type neuropeptides inhibit feeding behaviour, an effect that is consistent with 358 
findings from arthropods, including blowflies19 and shrimps20. Furthermore, a 359 
luqin/RYamide-type neuropeptide was found to have excitatory effects on neurons and 360 
muscles involved in feeding behaviour in the mollusc A. fulica7. Starfish feed by everting 361 
their cardiac stomach out of their mouth and over the digestible parts of prey and therefore 362 
our finding that cells expressing ArLQP are particularly abundant in the cardiac stomach of 363 
A. rubens is consistent with the notion that luqin/RYamide-type neuropeptides may also 364 
regulate aspects of feeding behaviour in this species. 365 
In conclusion, although the luqin precursor was first identified in the mollusc A. 366 
californica as long ago as 1986, it has attracted relatively little interest in the following three 367 
decades. With the discovery and functional characterisation of orthologs of the luqin 368 
signalling pathway in the ecdysozoa (RYamides) and in the ambulacraria (RWamides), as 369 
reported here, opportunities to gain a deeper understanding of the evolution and comparative 370 
physiology of this bilaterian neuropeptide system have emerged. The loss of 371 
luqin/RYamide/RWamide-type neuropeptides in the chordate lineage may at least in part 372 
! 13!
explain why this signalling system has attracted relatively little attention, but it remains of 373 
interest to address the question of why it was lost. Furthermore, the occurrence of 374 
neuropeptide signalling systems in invertebrates that have been lost in vertebrates may have 375 
practical applications in the development of compounds that can be used to control 376 
invertebrate pests without effects on humans and other vertebrates.  377 
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Materials and Methods 378 
Animals. Starfish (A. rubens) were collected at low tide from a location near Margate 379 
(Kent, UK) or were obtained from a fisherman based at Whitstable (Kent, UK). The animals 380 
were maintained in a circulating seawater aquarium at ~12oC in the School of Biological and 381 
Chemical Sciences at Queen Mary University of London and were fed on mussels (Mytilus 382 
edulis) also collected near Margate.  383 
 384 
Cloning of a cDNA encoding the Asterias rubens luqin precursor and sequence 385 
alignment with other luqin/RYamide-type neuropeptide precursors. A transcript 386 
encoding the A. rubens luqin-type precursor (ArLQP) has been identified previously 387 
(GenBank: KT601719; Semmens et al., 2016). Here a cDNA containing the complete open 388 
reading frame of ArLQP was amplified by PCR from A. rubens radial nerve cord total 389 
cDNA using specific primers (see supplementary table 1) and Q5 proofreading polymerase 390 
(NEB; Cat. No. M0491S), cloned into pCR-Blunt II TOPO vector (Invitrogen; Cat. No. 391 
K280002) and sequenced (TubeSeq service; Eurofins Genomics). The amino acid 392 
sequence of ArLQP was aligned with luqin/RYamide-type precursors from other species 393 
(see supplementary table 2 for a list of the sequences) using MAFFT version 7 (5 iterations, 394 
substitution matrix; BLOSUM62) and highlighted using the software BOXSHADE 395 
(www.ch.embnet.org/software/BOX_form.html) with 70% conservation as the minimum for 396 
highlighting.  397 
 398 
Identification of the ArLQP-derived neuropeptide ArLQ in an extract of A. rubens 399 
radial nerve cords using mass spectrometry. Radial nerve cords from two A. rubens 400 
animals were dissected and transferred to a micro-centrifuge tube containing 3% acetic acid 401 
(in ddH2O). The tube was incubated in a boiling water bath for 10 minutes. The nerve cords 402 
were then sonicated and homogenized to lyse cells. The extract was centrifuged, supernatant 403 
transferred to a glass vial and solvent was bubbled-off using nitrogen gas. Frozen radial nerve 404 
cords extracts were thawed and an aliquot diluted 10-fold with 0.1% aqueous formic acid, 405 
then filtered through a 0.22 µm Costar Spin-X centrifuge tube filter to remove particulates. 406 
The extract was analysed by means of nanoflow liquid chromatography with electrospray 407 
ionisation quadrupole time-of-flight tandem mass spectrometry (nanoLC-ESI-MS/MS) using 408 
a nanoAcquity UPLC® system coupled to a Synapt G2 HDMS mass spectrometer and 409 
MassLynx v4.1 SCN 908 software (Waters Corporation, Milford, MA, USA). The mobile 410 
phases used for the chromatographic separation were: 0.1% aqueous formic acid (mobile 411 
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phase A) and 0.1% formic acid in acetonitrile (mobile phase B). An aliquot containing 15 µL 412 
of the extract was applied to a trapping column (Symmetry C18 180 µm × 20 mm, 5 µm 413 
particle size, 100 Å pore size, Waters Corporation) using 99.9% mobile phase A at a flow 414 
rate of 10 µL min−1 for 3 min, after which the fluidic flow path included the analytical 415 
capillary column (HSS T3 75 µm×150 mm, 1.8 µm particle size, 100 Å pore size, Waters 416 
Corporation). A linear gradient of 5–40% mobile phase B over 105 min was utilized with a 417 
total run time of 120 min. Nanoflow ESI source conditions were as follows: capillary voltage 418 
3.5 kV, sample cone voltage 25 V with a source temperature of 80°C. The instrument was 419 
operated in resolution mode (~20,000 measured at full width half height). A data-dependent 420 
acquisition was performed that would trigger an MS/MS scan on any multiply charged 421 
peptide of intensity ≥ 450 counts/sec within the survey scan m/z range 300-1950. A 422 
maximum of 5 precursor peptides were selected for MS/MS from each survey scan and 423 
MS/MS data collected for 6 scans then combined. Each peptide precursor was then excluded 424 
from selection for MS/MS for a period of 20 sec. MS/MS data was collected over m/z range 425 
50-1950 using m/z and charge state dependent collision energy applied to the trap region. 426 
Tandem mass spectra were extracted by ProteinLynx Global Server version 2.5.1 (Waters 427 
Corporation, Milford, MA, USA) with charge state deconvolution and deisotoping performed 428 
prior to creation of a peak list file for each sample. A peak list file generated from acetic acid 429 
extract data was used to interrogate protein database UniProtKB/TrEMBL release 2018_02 430 
filtered for taxon identifier 7586 (phylum Echinodermata) containing 70,885 sequences and 431 
29,368,428 residues (http://www.uniprot.org/). Search parameters used by Mascot software 432 
(Matrix Science, London, UK; version 2.5.1) were “none” for enzyme i.e. Mascot searched 433 
each protein sequence for every sub-sequence meeting the remaining search criteria, 434 
precursor mass error less than 5 ppm and fragment ion tolerance 20 mDa. A variable 435 
modification of C-terminal amidation was permitted. 436 
 437 
Identification of luqin/RYamide-type receptors in A. rubens and phylogenetic 438 
analysis of bilaterian luqin/RYamide-type receptors. To identify candidate receptors 439 
for ArLQ, A. rubens neural transcriptome sequence data were analysed by BLAST using 440 
the Platynereis dumerilii (phylum Annelida) luqin-type receptor10 as the query sequence. 441 
Contigs (1121303 and 1122311) containing the complete open reading frames of two 442 
luqin-type receptors were identified and the sequences of the 347 and 388 residue proteins 443 
encoded by these two transcripts were determined using the ExPASy translate tool 444 
(http://web.expasy.org/translate/) and named ArLQR1 and ArLQR2, respectively. To further 445 
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investigate the relationship of ArLQR1 and ArLQR2 with luqin/RYamide-type receptors 446 
from other species (see supplementary table 3 for a list of sequences), a phylogenetic analysis 447 
was performed using the maximum-likelihood method. Receptor sequences were aligned 448 
using the MUSCLE plugin in MEGA 7 (iterative, 10 iterations, UPGMB as clustering 449 
method)40,41 and the alignment was manually trimmed to 299 residues that span from the first 450 
to the seventh transmembrane domains. The maximum-likelihood tree was built using 451 
PhyML version 3.0 (1000 bootstrap replicates, LG substitution model)42. 452 
 453 
Pharmacological characterisation of ArLQR1 and ArLQR2. To enable 454 
pharmacological characterisation of ArLQR1 and ArLQR2, cDNAs encoding these 455 
receptors were amplified by PCR, using A. rubens radial nerve cord total cDNA, specific 456 
primers (see supplementary table 1 for a list of the primers) and Q5 polymerase (NEB; 457 
Cat. No. M0491S). First, the receptor cDNAs were ligated into the phagemid vector 458 
pBluescript II SK+ (Agilent Technologies; Cat. No. 212205) using a blunt-end ligation 459 
method. The vector was cut with the restriction enzyme EcoRV (NEB; Cat. No. R0195S) 460 
and the ligation was performed using T4 DNA ligase (NEB; Cat. No. M0202S). Successful 461 
ligation was confirmed by PCR, restriction enzyme digestion and sequencing (TubeSeq 462 
service; Eurofins Genomics). The receptor cDNAs were then sub-cloned into the 463 
eukaryotic expression vector pcDNA 3.1(+) (Invitrogen; Cat. No. V790-20). To 464 
accomplish this, forward primers included the partial Kozak consensus sequence (ACC) 465 
and a sequence corresponding to the first 21 bases of the ArLQR1 or ArLQR2 ORFs, 466 
including the start codon. Reverse primers consisted of a stop codon and a sequence 467 
reverse complementary to the ORF encoding the C-terminal region of ArLQR1 or 468 
ArLQR2 (see supplementary table 1 for a list of the primers). PCR was performed using 469 
Q5 polymerase NEB and the cDNA products were ligated into the pcDNA 3.1(+) vector 470 
that had been cut previously with the restriction enzyme EcoRV by performing blunt-end 471 
ligation with T4 DNA ligase NEB. The direction of the insert was determined by restriction 472 
enzyme digestion and sequencing. The ArLQR1 and ArLQR2 sequences have been 473 
deposited in the GenBank database under accession numbers MG744509 and MG744510 474 
respectively. 475 
To determine if ArLQ acts as a ligand for ArLQR1 and/or ArLQR2, the receptors 476 
were expressed in Chinese hamster ovary cells (CHO-K1) stably expressing the calcium-477 
sensitive bioluminescent reporter GFP-aequorin fusion protein (G5A)43. CHO-K1 cells were 478 
maintained at 37°C in T25 culture flasks (USA Scientific; Cat. No. CC7682-4325) containing 479 
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6 ml of DMEM/F12 Nutrient Mixture medium (Thermo Fisher Scientific; Cat. No. 480 
11039047) supplemented with 10% fetal bovine serum (Thermo Fisher Scientific; Cat. No. 481 
10082147), Antibiotic-Antimycotic 1x (Thermo Fisher Scientific, Cat. No. 15240062) and 482 
200 µg/ml of Geneticin G418 sulfate (Thermo Fisher Scientific, Cat. No. 10131035). Upon 483 
reaching a confluency of approximately 80%, cells were transfected with the plasmids 484 
containing ArLQR1 or ArLQR2 receptor cDNAs and a plasmid containing the promiscuous 485 
Gα-16 protein that can couple a wide range of GPCRs to the phospholipase C pathway44. The 486 
transfection was achieved using 5 µg of each plasmid and 8 µl of the transfection reagent 487 
Lipofectamine 3000 following the manufacturer instructions (Thermo Fisher Scientific; Cat. 488 
No. L3000008). Two days post-transfection, the culture medium was removed and the cells 489 
detached by the addition of 2 ml of 1 X PBS buffer pH 7.4 (Thermo Fisher Scientific; Cat. 490 
No. 10010023) supplemented with UltraPure EDTA 0.5M pH 8.0 (Thermo Fisher Scientific; 491 
Cat. No. 15575020) to a final concentration of 5 mM EDTA. The cells were collected by 492 
centrifugation at 4000 rpm in an Eppendorf 5702 centrifuge (Eppendorf; Cat. No. 493 
022626001) and the PBS-EDTA was replaced with DMEM/F12 Nutrient Mixture medium 494 
supplemented with 1 mM coelenterazine-H (Thermo Fisher Scientific; Cat. No. C6780). 495 
After an incubation period of 3 hr, cells were exposed to synthetic ArLQ peptide 496 
(EEKTRFPKFMRW-NH2; Peptide Protein Research Ltd., Fareham, UK) diluted in 497 
DMEM/F12 Nutrient Mixture medium in concentrations ranging from 10−4"M to 10−14"M in 498 
clear bottom 96-well plates (Sigma-Aldrich; Cat. No. CLS3603-48EA). Luminescence levels 499 
were recorded over a 35-second period using a FLUOstar Omega Plate Reader (BMG 500 
LABTECH; FLUOstar Omega Series multi-mode microplate reader). Data were integrated 501 
over the 35-second measurement period. Triplicate measurements were made for each 502 
concentration, and the average of each was used to normalise the responses. Responses were 503 
normalised to the maximum response obtained in each experiment (100% activation) and to 504 
the response obtained with the vehicle media (0% activation). Dose-response curves were 505 
fitted with a four-parameter curve and EC50 values were calculated from dose–response 506 
curves based on at least three measurements from three independent transfections using 507 
Prism 6 (GraphPad, La Jolla, USA).  508 
 509 
Localisation of ArLQP expression in A. rubens using mRNA in situ hybridisation. To 510 
generate probes for localisation of ArLQP expression in A. rubens, 5 µg of purified Zero 511 
Blunt® Topo vector plasmid containing the ArLQ precursor cDNA was linearised using the 512 
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restriction enzymes BamH1 (NEB; Cat. No. R0136T) for the antisense probe and Xho1 513 
(NEB; Cat. No. R0146S) for the sense probe. The linearised plasmids were cleaned by 514 
phenol:chloroform 1:1 and chloroform:isoamyl-alcohol 24:1 purification. Once purified, the 515 
DNA was precipitated by adding 1/10 volume of 3 M sodium acetate and 2.5 volumes of 100 516 
% isopropanol and incubating at -80oC for 30 min. Following centrifugation for 10 min at 517 
13,000 rpm in an Eppendorf 5424R centrifuge (Eppendorf; Cat. No. 5404000138) at 4 °C, the 518 
precipitated DNA was washed with 70% ice-cold ethanol before air drying and re-suspending 519 
in RNAse-free water.  520 
Sense and antisense RNA probes were synthesised using 1 µg of the previously 521 
linearised plasmid DNA as a template, 0.5 mM digoxigenin RNA labelling mix (Roche, 522 
Basel, Switzerland, Cat. No. 11277073910), 1x transcription buffer (NEB, Ipswich, USA, 523 
Cat. No. M0251S), 5 mM dithiothreitol (Promega, Madison, USA, Cat. No. P1171), 1 U/µl 524 
placental ribonuclease inhibitor (NEB, Ipswich, USA, Cat. No. M0307S) and 5 U/µl of T7 525 
RNA polymerase (NEB, Ipswich, USA, Cat. No. M0251S) for the antisense probe or 5 U/µl 526 
of SP6 RNA polymerase for the sense probe (NEB, Ipswich, USA, Cat. No. M0207S). The 527 
mixture was incubated for 2 hours at 37 °C to allow the in vitro transcription. The 528 
synthesised probes were purified and precipitated using the same method described for the 529 
plasmid, and stored in 25% formamide (FA) / 2x saline-sodium citrate buffer (SSC) at -20 530 
°C. Sections of the arms and central disk of A. rubens were prepared and processed for 531 
mRNA in situ hybridisation using the same methods reported previously for the neuropeptide 532 
precursor ArRGPP45. Images of stained sections were captured using a DMRA2 light 533 
microscope (Leica) with a MicroPublisher 5.0 Real-Time Viewing (RTV) digital colour 534 
camera (QImaging) and Volocity® v.5.3.1 image analysis software (PerkinElmer). Montages 535 
of photographs were prepared using the software Adobe Photoshop CC 2015. 536 
 537 
Investigation of the in vitro pharmacological effects of ArLQ on tube foot and cardiac 538 
stomach preparations from A. rubens   Informed by findings from analysis of the 539 
expression of ArLQP in A. rubens (see results), synthetic ArLQ (custom synthesized by PPR 540 
Ltd, Fareham, UK) was tested on tube foot and cardiac stomach preparations from A. rubens. 541 
The SALMFamide neuropeptide S2 (SGPYSFNSGLTF-NH2) was used as control peptide for 542 
these experiments because it has been shown to as act as a relaxant of all three of these 543 
preparations34. Tube foot preparations were obtained by dissecting from starfish arms a small 544 
square-shaped piece of ambulacral body wall containing a single tube foot stem and its 545 
associated ampulla. Cotton ligatures were tied around the body wall and the tube foot disk, as 546 
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illustrated previously34. Cardiac stomach preparations were dissected and prepared as 547 
previously described46. In both cases one ligature was attached to a fixed metal hook in a 20-548 
ml glass organ bath containing artificial seawater at ~11oC. The other ligature was tied to a 549 
High Grade Isotonic Transducer (ADinstruments MLT0015, Oxford, UK) connected to 550 
PowerLab data acquisition hardware (ADinstruments PowerLab 2/26, Oxford, UK). Output 551 
from PowerLab was recorded using LabChart (v8.0.7) software installed on a laptop 552 
computer (Lenovo E540, Windows 7 Professional). The preparations were left for an 553 
equilibration period of ~10 min. To enable observation of potential relaxing effects of ArLQ, 554 
tube foot preparations were pre-contracted by the addition of 10 µM acetylcholine. Once a 555 
stable baseline contracted state was reached, synthetic ArLQ or S2 (control) was added to 556 
achieve organ bath concentrations between 10-9 M and 10-5 M. In the case of the cardiac 557 
stomach, contraction was induced by using artificial seawater supplemented with 30 mM 558 
KCl, and again peptides were added once a stable baseline contracted state was reached. 559 
Cumulative dose-response curves were constructed by expressing relaxation as a percentage 560 
reversal of the contraction induced by ACh. Each peptide concentration was tested on at least 561 
four preparations from 4 different animals.  562 
 563 
Data availability. Data generated or analysed during this study are included in this 564 
published article or in its Supplementary Information files or are available from the 565 
corresponding author on reasonable request. The sequences of cDNAs encoding ArLQP, 566 
ArLQR1, ArLQR2, ArTKR1 and ArTKR2 have been deposited in GenBank under accession 567 
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Figure legends 770 
 771 
Figure 1. Asterias rubens luqin-type precursor (ArLQP) and luqin-type neuropeptide 772 
(ArLQ). A. Amino acid sequence of ArLQP, with the predicted signal peptide shown in blue, 773 
the predicted luqin-type neuropeptide shown in red and a potential dibasic cleavage site 774 
shown in green. Shown in purple is a region of the precursor near to the C-terminus 775 
containing two cysteine residues (underlined), which is a conserved feature of luqin-type 776 
precursors (see alignment in C). B. Mass spectrometric identification of ArLQ 777 
(EEKTRFPKFMRW-NH2) from an acetic acid extract of radial nerve cords from A. rubens. 778 
Annotated MS/MS spectrum indicated in red, with ions matched to the sequence used for 779 
Mascot scoring. A triply charged peptide was identified with a Mascot ions score of 45, 780 
expect value of 0.00018 based on UniProt/TrEMBL protein database filtered for taxon 781 
identifier 7586 (Echinodermata, 70,885 sequences) with a precursor mass error of 2.7 ppm. 782 
C. Alignment of the N-terminal neuropeptide-containing region and C-terminal region of 783 
ArLQP with corresponding regions of other luqin/RYamide-type precursor proteins. 784 
Conserved residues are highlighted in black or grey. The C-terminal residues of the 785 
luqin/RYamide-type peptides and species names are highlighted in phylum-specific colours: 786 
light blue (Echinodermata), dark blue (Hemichordata), pink (Annelida), red (Mollusca), 787 
Priapulida (yellow), green (Arthropoda) and purple (Nematoda). Species names are as 788 
follows: Arub (Asterias rubens), Ovic (Ophionotus victoriae), Ajap (Apostichopus 789 
japonicus), Spur (Strongylocentrotus purpuratus), Skow (Saccoglossus kowalevskii), Ctel 790 
(Capitella teleta), Obim (Octopus bimaculoides), Cgig (Crassostrea gigas), Acal (Aplysia 791 
californica), Aful (Achatina fulica), Iobs (Ilyanasa obsoleta), Bgla (Biomphalaria glabrata), 792 
Pcau (Priapulus caudatus), Tcas (Tribolium castaneum), Dmel (Drosophila melanogaster), 793 
Aaeg (Aedes aegypti), Tsui (Trichuris suis), Cele (Caenorhabditis elegans). The accession 794 
numbers of the sequences included in this alignment are listed in supplementary table 2. 795 
 796 
Figure 2. Phylogenetic tree showing luqin/RYamide-type receptors from bilaterians, 797 
including the starfish A. rubens, and other closely related neuropeptide receptors. The 798 
tree, which was generated in PHYML 3.042 using the Maximum likelihood method47,48, 799 
comprises three distinct receptor clades – luqin/RYamide-type receptors, tachykinin-type 800 
receptors, neuropeptide-Y-type receptors, with TRH-type receptors as an outgroup. Taxa are 801 
colour-coded and bootstrap support (1000 replicates;49) for clades is represented with 802 
coloured stars, as explained in the key. Species in which the peptide ligands that activate 803 
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luqin/RYamide-type receptors have been identified experimentally are shown with blue 804 
lettering. Species names are as follows: Aaeg (Aedes aegypti), Acal (Aplysia californica), 805 
Apis (Acyrthosiphon pisum), Arub (Asterias rubens), Cele (Caenorhabditis elegans), Cint 806 
(Ciona intestinalis), Ctel (Capitella teleta), Dmel (Drosophila melanogaster), Dpul (Daphnia 807 
pulex), Hsap (Homo sapiens), Lgig (Lottia gigantea), Lsta (Lymnaea stagnalis), Obim 808 
(Octopus bimaculoides), Ovul (Octopus vulgaris), Pcau (Priapulus caudatus), Pdum 809 
(Platynereis dumerilii), Skow (Saccoglossus kowalevskii), Spur (Strongylocentrotus 810 
purpuratus), Tcas (Tribolium castaneum), Tsui (Trichuris suis), Uuni (Urechis unicinctus). 811 
The accession numbers of the sequences included in this phylogenetic tree are listed in the 812 
supplementary table 3.  813 
 814 
Figure 3. ArLQ acts as a ligand for two A. rubens G-protein coupled receptors, 815 
ArLQR1 and ArLQR2. The graphs show that ArLQ causes dose-dependent activation of 816 
ArLQR1 (A, red) and ArLQR2 (B, blue) expressed in CHO-K1 cells expressing the 817 
promiscuous Gα16 protein and a calcium-sensitive bioluminescent GFP-aequorin fusion 818 
protein (G5A). Each point represents mean values (± S.E.M.) from at least four independent 819 
experiments, with each experiment performed in triplicate. Control experiments where cells 820 
were transfected with an empty pcDNA 3.1(+) vector are shown in black. Luminescence is 821 
expressed as a percentage of the maximal response observed in each experiment. The EC50 822 
values for activation of ArLQR1 and ArLQR2 with ArLQ are 2.4 x 10-8 M and 7.8 x 10-10 M, 823 
respectively.  824 
 825 
Figure 4. Localisation of ArLQP expression in the nervous system of A. rubens using 826 
mRNA in situ hybridisation (A) Schematic showing the anatomy of the starfish arm as seen 827 
from a transverse section. (B) Schematic showing the anatomy of a radial nerve cord as seen 828 
in transverse section. (C) Transverse section of a radial nerve cord showing stained cells 829 
concentrated in the lateral parts of the ectoneural region. Higher magnification images of the 830 
boxed regions are shown in the panels (D) and (E). The inset shows absence of staining in a 831 
transverse section of radial nerve cord incubated with sense probes, demonstrating the 832 
specificity of staining observed with antisense probes. (F). Longitudinal parasagittal section 833 
of a radial nerve cord showing stained cells in the ectoneural region (arrowheads). A higher 834 
magnification of the boxed region is shown in the panel (G). (H) Transverse section of the 835 
circumoral nerve ring showing stained cells concentrated the lateral part of the ectoneural 836 
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region. The boxed region is shown at higher magnification in panel I. am, apical muscle; 837 
conr, circumoral nerve ring; cut, cuticle; ec, ectoneural region; g, gonads; hy, hyponeural 838 
region; mn, marginal nerve; pc, pyloric caeca; pm, peristomial membrane; rhs, radial hemal 839 
sinus; rnc, radial nerve cord; tf, tube foot. Scale bars: 50 µm in C, C inset, F, H; 10 µm in D, 840 
E, G, I.  841 
 842 
Figure 5. Localisation of ArLQP mRNA in the tube feet and stomach of A. rubens using 843 
by in situ hybridisation. (A) Schematic showing the anatomy of the central disk region and 844 
an adjoining arm in starfish. (B) Longitudinal section of a tube foot showing stained cells 845 
(arrowheads) associated with the basal nerve ring in the disk region. (C) High magnification 846 
image showing stained cells (arrowheads) associated with the basal nerve ring in the disk 847 
region of a tube foot. (D) Transverse section of the central disk region showing stained cells 848 
in the cardiac stomach and pyloric stomach. A higher magnification of the boxed region of 849 
the cardiac stomach is shown in (E), where stained cells can be seen in the mucosal layer of 850 
the cardiac stomach, with some cells (arrowheads) in close proximity to the basi-epithelial 851 
nerve plexus. A higher magnification image of a stained cell in the pyloric stomach is shown 852 
in (F). a, anus; amp, ampulae; as, axial sinus; bnr, basal nerve ring; conr, circumoral nerve 853 
ring; cs, cardiac stomach; g, gonad; gcc, general coelomic cavity; l, lumen; m, mouth; md, 854 
madreporite; ms, mesentery; o, ossicle; p, papillae; pc, pyloric caecum; pd, pyloric duct; pdl, 855 
pyloric duct lumen; pm, peristomial membrane; ps, pyloric stomach; rc, rectal caecum; rca, 856 
ring canal; rn, radial nerve; rw, radial water vascular canal; sc, stone canal; tb, Tiedemann’s 857 
bodies; tf, tube foot; tfd, tube foot disc. Scale bars: 50 µm in B, D; 20 µm in C; 10 µm in E 858 
and F. 859 
 860 
Figure 6. ArLQ causes relaxation of in vitro preparations of tube feet from A. rubens. 861 
(A) Representative recording of an experiment where ArLQ (1 µM) causes partial reversal of 862 
acetylcholine (ACh; 10 µM) induced contraction of an in vitro preparation of a tube foot 863 
from A. rubens. (B). Graphs showing the dose-dependent relaxing effect of ArLQ (red) on 864 
tube foot preparations in comparison with a known tube foot relaxant, the SALMFamide 865 
neuropeptide S2 (blue). Each point represents the mean ± S.E.M. from at least 6 different 866 
experiments, with the effect calculated as the percentage reversal of contraction induced by 867 
10 µM ACh.  868 
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Figure 7. Phylogenetic diagram showing the occurrence and characteristics luqin-type 869 
neuropeptide signalling in the Bilateria. The phylogenetic tree shows relationships of 870 
selected bilaterian phyla. Phyla in which luqin-type precursors and luqin-type receptors have 871 
been identified are labelled with purple-filled boxes. The number in the precursor box 872 
indicates how many mature luqin-like neuropeptides are derived from the precursor, with a 873 
hashtag indicating mixed features. The inclusion of an asterisk in the receptor boxes indicates 874 
that the peptide ligand that activates the receptor has been determined experimentally. Note 875 
that the starfish Asterias rubens is the first and only deuterostome in which the neuropeptide 876 
ligand for luqin-type receptors has been identified. Note also the loss of the luqin-type 877 
signalling system in the chordate lineage, which is signified by the X and the white-filled 878 
boxes. C-terminally aligned peptides that are predicted/proven ligands for luqin-type 879 
receptors in the species listed are shown on the right side of the figure, illustrating that 880 
peptides with a C-terminal RWamide motif occur in ambulacrarians, peptides with a C-881 
terminal RFamide motif occur in lophotrochozoans and peptides with a C-terminal RYamide 882 
motif occur in ecdysozoans. Species names are as follows: Arub (Asterias rubens), 883 
Skow (Saccoglossus kowalevskii), Pdum (Platynereis dumerilii), Lsta (Lymnaea stagnalis), 884 
Pcau (Priapulus caudatus), Dmel (Drosophila melanogaster), Cele (Caenorhabditis elegans). 885 
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Supplementary figure 1. Neighbour-joining tree1 showing relationships of Luqin, RYamide, and RWamide precursors. The percentage of replicate trees in 
which the associated taxa clustered together in the bootstrap test (5000 replicates) are shown next to the branches and are represented with coloured stars, as 
explained in the key. The analysis was conducted in MEGA 72. Species names are as follows; Aaeg (Aedes aegypti), Acal (Aplysia californica), Aful 
(Achatina fulica), Ajap (Apostichopus japonicus), Arub (Asterias rubens), Bgla (Biomphalaria glabrata), Cele (Caenorhabditis elegans), Cgig (Crassostrea 
gigas), Ctel (Capitella teleta), Dmel (Drosophila melanogaster), Iobs (Ilyanasa obsoleta), Obim (Octopus bimaculoides), Ovic (Ophionotus victoriae), Pcau 
(Priapulus caudatus), Skow (Saccoglossus kowalevskii), Spur (Strongylocentrotus purpuratus), Tcas (Tribolium castaneum), Tsui (Trichuris suis). The 
accession numbers of the sequences included in this tree are shown in supplementary table 2.
 
 
Supplementary figure 2. Prediction of the transmembrane domains of ArLQR1. The seven transmembrane 
domains are numbered successively in blue and N-glycosylation sites are shown with green boxes. In silico 
analysis of the amino acid sequence of this receptor was made using Protter3. 
  
 
Supplementary figure 3. Prediction of the transmembrane domains of ArLQR2. The seven transmembrane 
domains are numbered successively in blue and N-glycosylation sites are shown with green boxes. In silico 
analysis of the amino acid sequence of this receptor was made using Protter3. 
 
Supplementary figure 4. Graphs showing the dose-dependence and kinetics of ArLQ activation of ArLQR1 (A) and ArLQR2 (B) in a representative 
experiment. Luminescence was recorded over a period of 35 seconds, with injection of receptor-expressing CHO cells occurring in the 5th second of the 
experiment, as labelled with an arrow. The concentrations of the ArLQ peptide tested range from 1x10-4 to 1x10-14, as shown in the key. 
 
Supplementary figure 5. Graphs showing the selectivity of ArLQR1 (A) and ArLQR2 (B) as receptors for 
ArLQ. Thus, ArLQ causes dose-dependent activation of both receptors, whereas other starfish neuropeptides 
tested do not activate the receptors. Key: S2, SALMFamide-2; ArNPY, A. rubens neuropeptide-Y-type 





Supplementary figure 6. Determination of the best amino acid substitution model for maximum-likelihood 
based phylogenetic analysis of the receptors analysed in this study. Amino acid substitution models are shown in 
descending order, with the best model corresponding to the LG substitution model. This analysis was conducted 





Supplementary figure 7. ArLQ does not cause relaxation of in vitro preparations of cardiac stomach from A. 
rubens. Representative recording of an experiment where ArLQ (1 µM) was added after the induced contraction 












Primers used for cloning of ArLuqin precursor cDNA 
  Sequence Length  Calculated melting temperature ºC 
Forward primer 5' to 3' TAGTCGGTGTGAAGGCTCTG 20 56.4 
Reverse primer 5' to 3'  AGATGTCTCGTCGTTTCGGT 20 56 
        
Primers used for cloning of ArLuqin receptor 1 (ArLQR1) cDNA in pBlueScript II SK (+) 
  Sequence Length (pb) Calculated melting temperature ºC 
Forward primer 5' to 3' ATGTCGGGATTAACAATATC 20 57 
Reverse primer 5' to 3'  TCACATGAAAGATGTTCTTGT 21 57.3 
Primers used for cloning of ArLuqin receptor 1 (ArLQR1) cDNA in pcDNA3.1 + 
 
Sequence Length (pb) Calculated melting temperature ºC 
Forward primer 5' to 3' ACCATGTCGGGATTAACAA 19 60.1 
Reverse primer 5' to 3'  TCACATGAAAGATGTTCTTGT 21 57.3 
        
Primers used for cloning of ArLuqin receptor 2 (ArLQR2) cDNA in pBlueScript II SK (+) 
  Sequence Length  Calculated melting temperature ºC 
Forward primer 5' to 3' ATGAATATATCGTACAGCAA   20 52 
Reverse primer 5' to 3'  TCAGGATTGCATGTGTGTATT 21 60 
Primers used for cloning of ArLuqin receptor 2 (ArLQR2) cDNA in pcDNA3.1 + 
  Sequence Length  Calculated melting temperature ºC 
Forward primer 5' to 3' ACCATGAATATATCGTACAGC 21 56.5 
Reverse primer 5' to 3'  TCAGGATTGCATGTGTGTATT 21 60 
        
  
ACCATG* Partial kozak sequence used for expression in mammalian cells 
 
 




Abbreviation Species name Accesion number Protein Taxa Phyla 
Arub Asterias rubens ALJ99961.1 Luqin-type Deuterostome Ambulacraria (echinoderm) 
Ovic Ophionotus victoriae MF155242.1 Luqin-type Deuterostome Ambulacraria (echinoderm) 
Ajap Apostichopus japonicus ISOTIG 13831 Luqin-type Deuterostome Ambulacraria (echinoderm) 
Spur Strongylocentrotus purpuratus XP_003723362.1 Luqin-type Deuterostome Ambulacraria (echinoderm) 
Skow Saccoglossus kowalevskii XR_438635.1 Luqin-type Deuterostome Ambulacraria (hemichordate) 
Ctel Capitella teleta ELU01624.1  Luqin-type Protostome Lophotrochozoa (annelid) 
Pdur Platynereis durmerilii AHB62380.1  Luqin-type Protostome Lophotrochozoa (annelid) 
Obim Octopus bimaculoides XP_014774083.1 Luqin-type Protostome Lophotrochozoa (mollusc) 
Cgig Crassostea gigas XP_011447715.1 Luqin-type Protostome Lophotrochozoa (mollusc) 
Acal Aplysia californica  NP_001191480.1  Luqin  Protostome Lophotrochozoa (mollusc) 
Aful Achatina fulica BAA76406.1  Luqin-type Protostome Lophotrochozoa (mollusc) 
Iobs Ilyanasa obsoleta FK719020.1 Luqin-type Protostome Lophotrochozoa (mollusc) 
Bgla Biomphalaria glabrata XP_013066378.1  Luqin-type Protostome Lophotrochozoa (mollusc) 
Pcau Priapulus caudatus XP_014674262.1  RYamide Protostome Ecdysozoa (priapulid) 
Tcas Tribolium castaneum  NP_001280530.1  RYamide Protostome Ecdysozoa (arthropod) 
Dmel Drosophila melanogaster NP_001104382.3  RYamide Protostome Ecdysozoa (arthropod) 
Aaeg Aedes aegypti XP_001655654.1  RYamide Protostome Ecdysozoa (arthropod) 
Tsui Trichuris suis KFD52143.1 RYamide Protostome  Ecdysozoa (nematode) 
Cele Caenorhabditis elegans NP_001255160.1  RYamide Protostome  Ecdysozoa (nematode) 
 
Supplementary Table 2. Accession numbers of the neuropeptide precursor sequences used for the alignment in Figure 1 and Supplementary Figure 1. 
Ambulacrarian sequences are displayed with blue colour, Lophotrochozoan sequences with red colour and Ecdysozoan sequences with green colour.  
Abbreviation (Species name) Receptor type Accession numbers 
Arub (Asterias rubens) Luqin MG744509, MG744510 
Spur (Strongylocentrotus purpuratus) Luqin XP_783326.1, XP_783390.1 
Skow (Saccoglossus kowalevskii) Luqin XM_002731957.1, XM_002731958.1, XM_006813011.1, XM_002731956.1 
Acal (Aplysia californica) Luqin XP_012937781.1 
Lgig (Lottia gigantea)  Luqin XP_009064514.1, XP_009064591.1 
Lsta (Lymnea stagnalis)   Luqin AAB92258.1 
Obim (Octopus bimaculoides)  Luqin XP_014786450.1 
Ctel (Capitella teleta)  Luqin ELT96089.1 
Pdum (Platynereis dumerilii) Luqin KP420214.1 
Pcau (Priapulus caudatus) Luqin XP_014666446.1, XP_014678140.1 
Apis (Acyrthosiphon pisum) RYamide  XP_008178727.1, XP_003241610.1 
Tcas (Tribolium castaneum) RYamide  HQ709383.1 
Aae (Aedes aegypti) RYamide  AGX85003.1 
Dmel (Drosophila melanogaster) RYamide   P25931.2 
Cele (Caenorhabditis elegans) Luqin NP_001023541.1  
Tsui (Trichuris suis) Luqin KFD65303.1 
Hsap (Homo sapiens) Tachykinin   AAB20303.1, NP_001049.1, NP_001050.1 
Cint (Ciona intestinalis)  Tachykinin   XM_009863501.2 
Arub (Asterias rubens)  Tachykinin   MG744511, MG744512 
Spur (Strongylocentrotus purpuratus) Tachykinin   XP_011662258.1 
Ovul (Octopus vulgaris) Tachykinin   BAD93354.1  
Acal (Aplysia californica) Tachykinin   XP_012936180.1 
Lgig (Lottia gigantea)  Tachykinin   XP_009062052.1 
Ctel (Capitella teleta)  Tachykinin   ELT98449.1 
Uuni (Urechis unitinctus) Tachykinin   BAB87199.1 
Dmel (Drosophila melanogaster) Tachykinin   FBtr0085507 
Tcas (Tribolium castaneum) Tachykinin   XP_008194527.2 
Hsap (Homo sapiens) Neuropeptide Y/F   NP_001265724.1, NP_000900.1, NP_001304020.1 
Spur (Strongylocentrotus purpuratus) Neuropeptide Y/F  XP_003725178.1 
Lymnaea stagnalis Neuropeptide Y/F  CAA57620.1 
Pdum (Platynereis dumerilii) Neuropeptide Y/F  AKQ63001.1 
Dmel (Drosophila melanogaster) Neuropeptide Y/F  AAF51909.3 
Hsap (Homo sapiens) TRH  NP_003292.1 
Pdum (Platynereis dumerilii) TRH  AKQ63029.1 
Pcau (Priapulus caudatus) TRH  XP_014663378.1 
Dpul (Daphnia pulex) TRH  ADZ15312.1 
 




Platynereis dumerilii  
Bauknecht, P. & Jékely, G. Large-Scale Combinatorial Deorphanization of Platynereis Neuropeptide GPCRs. Cell Rep 12, 684–693 
(2015). 
Luqin Receptor  
Lymnaea stagnalis  
Tensen, C. P. et al. The lymnaea cardioexcitatory peptide (LyCEP) receptor: a G-protein-coupled receptor for a novel member of the 
RFamide neuropeptide family. J Neurosci 18, 9812–9821 (1998). 
RYamide Receptor  
Drosophila melanogaster  
Ida, T. et al. Identification of the novel bioactive peptides dRYamide-1 and dRYamide-2, ligands for a neuropeptide Y-like receptor in 
Drosophila. Biochem Biophys Res Commun 410, 872–877 (2011). 
RYamide Receptor  
Tribolium castaneum 
Collin, C. et al. Identification of the Drosophila and Tribolium receptors for the recently discovered insect RYamide neuropeptides. 
Biochem Biophys Res Commun 412, 578–583 (2011). 
Luqin Receptor  
Caenorhabditis elegans Ohno, H. et al. Luqin-like RYamide peptides regulate food-evoked responses in C. elegans. elife 6, (2017). 
Tachykinin Receptors  
Homo sapiens NK1-3 
Takeda, Y., Chou, K. B., Takeda, J., Sachais, B. S. & Krause, J. E. Molecular cloning, structural characterization and functional 
expression of the human substance P receptor. Biochem Biophys Res Commun 179, 1232–1240 (1991). 
Laburthe, M., Couvineau, A., Amiranoff, B. & Voisin, T. Receptors for gut regulatory peptides. Baillieres Clin Endocrinol Metab 8, 77–
110 (1994) 
Kurtz, M. M. et al. Identification, localization and receptor characterization of novel mammalian substance P-like peptides. Gene 296, 
205–212 (2002) 
Lecci, A., Capriati, A., Altamura, M. & Maggi, C. A. Tachykinins and tachykinin receptors in the gut, with special reference to NK2 
receptors in human. Auton Neurosci 126-127, 232–249 (2006). 
Tachykinin Receptor  
Ciona intestinalis 
Satake, H. et al. Tachykinin and tachykinin receptor of an ascidian, Ciona intestinalis: evolutionary origin of the vertebrate tachykinin 
family. J Biol Chem 279, 53798–53805 (2004). 
Tachykinin Receptor 
Octopus vulgaris 
Kanda, A., Takuwa-Kuroda, K., Aoyama, M. & Satake, H. A novel tachykinin-related peptide receptor of Octopus vulgaris-
evolutionary aspects of invertebrate tachykinin and tachykinin-related peptide. FEBS J 274, 2229–2239 (2007). 
Tachykinin Receptor 
Urechis unicinctus 
Kawada, T. et al. A novel tachykinin-related peptide receptor. Sequence, genomic organization, and functional analysis. Eur J 
Biochem 269, 4238–4246 (2002). 
Tachykinin Receptor 
Drosophila melanogaster 
Li, X. J., Wolfgang, W., Wu, Y. N., North, R. A. & Forte, M. Cloning, heterologous expression and developmental regulation of a 
Drosophila receptor for tachykinin-like peptides. EMBO J 10, 3221–3229 (1991). 
Neuropeptide Y  
Receptors 1, 4, 5 
Homo sapiens  
Tatemoto, K., Carlquist, M., Mutt, V. 1982. Neuropeptide V-A novel brain peptide with structural similarities to peptide YY and 
pancreatic polypeptide. Nature 296:659-60 
Wahlestedt, C. and Reis, D.J. (1993) Annu. Rev. Pharmacol. Toxicol. 32, 309-352 
Grundemar, L., Sheikh, S.P. and Wahlestedt, C. (1993) in: The Biology of Neuropeptide Y and Related Peptides, Humana Press Inc. 
(Totawa, New Jersey), pp. 197-239.  
Bard, J. A., Walker, M. W., Branchek, T. A. & Weinshank, R. L. Cloning and functional expression of a human Y4 subtype receptor 
for pancreatic polypeptide, neuropeptide Y, and peptide YY. J Biol Chem 270, 26762–26765 (1995).  
Neuropeptide Y receptor  
Lymnaea stagnalis 
Tensen, C. P. et al. Molecular cloning and characterization of an invertebrate homologue of a neuropeptide Y receptor. Eur J 
Neurosci 10, 3409–3416 (1998). 
Neuropeptide Y receptor 
Platynereis dumerilii 
Bauknecht, P. & Jékely, G. Large-Scale Combinatorial Deorphanization of Platynereis Neuropeptide GPCRs. Cell Rep 12, 684–693 
(2015). 
Neuropeptide F receptor 
Drosophila melanogaster 
Garczynski SF, Brown MR, Shen P, Murray TF, Crim JW (2002) Characterization of a functional neuropeptide F receptor from 
Drosophila melanogaster. Peptides 23: 773-780. doi:10.1016/ S0196-9781(01)00647-7. PubMed: 11897397. 
 




1. Saitou, N. & Nei, M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4, 406–425 (1987). 
 
2. Kumar, S., Stecher, G. & Tamura, K. MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol Biol Evol 33, 1870–1874 (2016). 
 
3. Omasits, U., Ahrens, C. H., Müller, S. & Wollscheid, B. Protter: interactive protein feature visualization and integration with experimental proteomic data. 
Bioinformatics 30, 884–886 (2014). 
 
4. Lefort, V., Longueville, J.-E. & Gascuel, O. SMS: smart model selection in phyml. Mol Biol Evol 34, 2422–2424 (2017). 
 
5. Guindon, S., Delsuc, F., Dufayard, J.-F. & Gascuel, O. Estimating maximum likelihood phylogenies with PhyML. Methods Mol Biol 537, 113–137 (2009). 
 
6. Guindon, S. et al. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol 59, 307–321 
(2010). 
 
 
